JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A3004 Vemurafenib (PLX4032, RG7204)
12 Citation

Target: Raf

Summary: BRAF kinase inhibitor

≥24.5 mg/mL
A3006 GDC-0068 (RG7440)
2 Citation

Target: Akt

Summary: Pan-AKT inhibitor,highly selective

≥22.9 mg/mL
A3011 CHIR-99021 (CT99021)
28 Citation

Target: GSK-3

Summary: GSK-3 inhibitor

≥23.27 mg/mL
A3021 GDC-0449 (Vismodegib)
11 Citation

Target: P-glycoprotein (P-gp)|Hedgehog

Summary: Hedgehog antagonist,potent and selective

≥21.08 mg/mL
A4005 RO4929097
6 Citation

Summary: γ secretase inhibitor

≥23.47 mg/mL
A2573 AEBSF.HCl
1 Citation

Target: Serine Proteases

Summary: serine protease inhibitor

≥12 mg/mL
A2577 Batimastat (BB-94)
17 Citation

Summary: MMP inhibitor

≥23.88 mg/mL
A4012 Gabexate mesylate

Summary: Trypsin-like serine proteinases inhibitor

≥102.4 mg/mL
A4078 Captopril

Summary: ACE inhibitor

≥21.7 mg/mL
A4082 Olmesartan medoxomil

Summary: AT1 receptor antagonist

≥21.1 mg/mL